GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis

E-ISSN： 2212-3873|17|4|285-296

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.17, Iss.4, 2017-11, pp. : 285-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

By Khalaf Mohamad M. Al

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-43

Adis International

Access to resources Recommend Favorite

Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis

By Wang Zexing Xu Jing Nie Weiwei Huang Guichun Tang Jinhai Guan Xiaoxiang

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 225-231

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Coenzyme Q10 Supplementation on Lipid Profiles Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2729-2742

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta‐analysis

Journal of Digestive Diseases, Vol. 17, Iss. 1, 2016-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Hepatic Events in Patients Treated with Vancomycin in Clinical Studies: A Systematic Review and Meta-Analysis

By Chen Yan > Zeckel Michael Killian Chris Hornbuckle Kenneth Regev Arie Voss Simon

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 73-82

Adis International

Access to resources Recommend Favorite